Green Thumb Industries (GTBIF) Notes Payables (2019 - 2026)
Green Thumb Industries (GTBIF) posted Notes Payables of $23.6 million for Q1 2026, up 27.49% on a QoQ basis from $18.5 million in Q4 2025, and up 68.76% year-over-year from $14.0 million in Q1 2025.
Green Thumb Industries (GTBIF) Notes Payables (2019 - 2026) Analysis & Trends
Green Thumb Industries' Notes Payables history runs 8 years deep, the most recent figure standing at $23.6 million for Q1 2026.
- Quarterly Notes Payables rose 68.76% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (up 68.76% YoY) and the FY2025 annual result came in at $18.5 million, up 53.33% from the prior year.
- Notes Payables was $23.6 million for Q1 2026 at Green Thumb Industries, up from $18.5 million in the prior quarter.
- Across five years, Notes Payables topped out at $227.3 million in Q2 2024 and bottomed at $900000.0 in Q1 2022.
- A 5-year average of $20.7 million and a median of $3.0 million in 2024 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables soared 21585.59% — and 2025, when it plunged 93.01%.
- Green Thumb Industries' Notes Payables stood at $1.0 million in 2022, then soared by 188.91% to $3.0 million in 2023, then jumped by 302.6% to $12.1 million in 2024, then jumped by 53.33% to $18.5 million in 2025, then rose by 27.49% to $23.6 million in 2026.
- Business Quant data shows GTBIF's Notes Payables at $23.6 million in Q1 2026, $18.5 million in Q4 2025, and $17.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.58 Mn |
| Dec 31, 2025 | 18.50 Mn |
| Sep 30, 2025 | 17.26 Mn |
| Jun 30, 2025 | 15.88 Mn |
| Mar 31, 2025 | 13.97 Mn |
| Dec 31, 2024 | 12.06 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 227.27 Mn |
| Mar 31, 2024 | 3.04 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 783,000.00 |
| Sep 30, 2021 | 777,275.00 |
| Jun 30, 2021 | 581,436.00 |